跳至主要内容
临床试验/ISRCTN17061437
ISRCTN17061437已完成不适用

Comparison of the effectiveness and tolerability of different doses of intravenous glucocorticoid for the treatment of moderately severe Graves' ophthalmopathy - EUGOGO study C

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 159 人开始时间: 2006年2月14日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
159

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Graves' hyperthyroidism, euthyroid for at least two months by antithyroid drugs or surgery (at least 6 months if I131 is used)
  • 2. Moderately severe Graves' ophthalmopathy defined as having at least one of the following signs:
  • 2.1. Class 2b-c
  • 2.2. Mono-ocular duction less than 30 degrees
  • 2.3. Diplopia Gorman score grade a-c
  • 3. Active Graves' ophthalmopathy (Clinical Activity Score [CAS] 3 or higher out of 7)
  • 4. No past treatment of the ophthalmopathy except for local measures
  • 5. Aged 18 - 70 years

排除标准

  • 1. CAS less than 3
  • 2. Clinically relevant optic nerve involvement
  • 3. General contra-indications to glucocorticoid infusions
  • 4. Pregnancy
  • 5. No informed consent
  • 6. Viral hepatitis
  • 7. Liver enzymes increased by a factor of 2

研究者

发起方
Academic Medical Centre (AMC) (The Netherlands)

相似试验

Comparison of the effectiveness and tolerability of... | 临床试验